Cancer risks of medical treatment. Part I: Monitoring for drug safety and efficacy.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002273:Carcinogens; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D009153:Mutagens; D012306:Risk; D013723:Teratogens
D000970:Antineoplastic Agents; D002273:Carcinogens; D006728:Hormones; D009153:Mutagens; D013723:Teratogens